研究発表 - 大家　基嗣

代用組織をフリーグラフトとして用いた尿道形成術の治療成績

高橋遼平、浅沼宏、田中伸之、武田利和、松本一宏、森田伸也、小坂威雄、水野隆一、大家基嗣

第16回泌尿器科再建再生研究会, 

2019年06月

AYA世代になって治療介入を要した先天性腎尿路異常（CAKUT）の臨床的検討

寺西悠、浅沼宏、田中伸之、武田利和、松本一宏、森田伸也、小坂威雄、水野隆一、篠島利明、大家基嗣

第16回泌尿器科再建再生研究会, 

2019年06月

Are there any significant impacts of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer?

Kosaka T, Hongo H, Mizuno R, Tanaka N, Takeda T, Matsumoto K, Oya M

ASCO Annual Meeting, 

2019年06月

Efficacy of systemic therapy for metastatic renal cell carcinoma in patients over 75 years of age

Mizuno R, Takamatsu K, Hayakawa N, Kosaka T, Tanaka N, Oya M

ASCO Annual Meeting, 

2019年06月

The Survival Prediction with time of Intravesical Recurrence in Upper Tract Urothelial Carcinoma

Ogihara K, Kikuchi E, Shigeta K, Hagiwara M, Mizuno R, Oya M

AUA Annual Meeting, 

2019年05月

内シャント閉鎖術後に入院加療が必要な血栓を形成した症例

環聡、森田伸也、北岡壮太郎、高橋遼平、松原健太郎、香野日高、浅沼宏、北川雄光、中川健、大家基嗣

第35回腎移植・血管外科研究会, 

2019年05月

生体腎移植後12年目に膜性腎症と診断され、直腸原発のPTLDが見つかり治療し得た一例

高橋遼平、森田伸也、北岡壮太郎、環聡、菊地拓、篠田和伸、香野日高、浅沼宏、橋口明典、中川健、大家基嗣

第35回腎移植・血管外科研究会, 

2019年05月

腎移植後ニューモシスチス肺炎に対してアトバコンで治療を行った2例

森田伸也、北岡壮太郎、高橋遼平、環聡、篠田和伸、馬場里英、小川卓範、浅沼宏、福永興壱、中川健、大家基嗣

第35回腎移植・血管外科研究会, 

2019年05月

UPJ狭窄のある単腎の腎動脈瘤に対し、後腹膜鏡下腎摘、腎動脈瘤切除、腎結石砕石、腎盂尿管形成、自家腎移植術を施行した症例

篠田和伸、松原健太郎、尾原秀明、森田伸也、環聡、浅沼宏、大家基嗣

第35回腎移植・血管外科研究会, 

2019年05月

Kidney graft damage after long cold ischemia time is attenuated by recombinant thrombomodulin alpha in a rat kidney transplant model

Tamaki S, Shinoda K, Shimoda M, Morita S, Takahashi R, Kitaoka S, Tanaka N, Takeda T, Matsumoto K, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Oya M

AUA Annual Meeting, 

2019年05月

Risk factors for hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma

Takeda T, Takamatsu K, Teranishi Y, Hakozaki K, Tanaka N, Matsumoto K, Morita S, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Oya M

AUA Annual Meeting, 

2019年05月

Could a history of non-muscle invasive bladder cancer have a prognostic role in cT2-4aN0M0 Bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy?

Kayama E, Kikuchi E, Hakozaki K, Tanaka N, Kaneko G, Shirotake S, Miyazaki Y, Yokomine S, Maeda T, Kanai K, Oyama M, Nakajima Y, Hara S, Monma T, Oya M

AUA Annual Meeting, 

2019年05月

Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy

Matsumoto K, Niwa N, Hagiwara M, Kosaka T, Tanaka N, Takeda T, Morita S, Mizuno R, Shinojima T, Hara S, Kikuchi E, Asanuma H, Oya M

AUA Annual Meeting, 

2019年05月

Overcoming cabazitaxel resistance by G2/M regulating genes in castration-resistant prostate cancer

Hongo H, Kosaka T, Yanai Y, Yasumizu Y, Miyazaki Y, Tanaka N, Matsumoto K, Mizuno R, Kikuchi E, Oya M

AUA Annual Meeting, 

2019年05月

Optimal subclassification system for intermediate-risk non-muscle invasive bladder cancer

Matsumoto K, Kikuchi E, Yanai Y, Hayakawa N, Niwa N, Maeda T, Asanuma H, Oya M

AUA Annual Meeting, 

2019年05月

A Novel Risk Based Approach Simulating Oncologic Surveillance According to Smoking Status after Radical Nephroureterectomy with Upper Tract Urothelial Carcinoma

Shigeta K, Kikuchi E, Hagiwara M, Abe T, Ogihara K, Mizuno R, Oya M

AUA Annual Meeting, 

2019年05月

Simulating the Surveillance Duration of Intravesical Recurrence After Radical Nephroureterectomy: An Individualized Risk Based Approach Applying the Weibull Model

Shigeta K, Kikuchi E, Hagiwara M, Abe T, Ogihara K, Mizuno R, Oya M

AUA Annual Meeting, 

2019年05月

Could Laparoscopic Surgery Have the Same Long-Term Oncological Outcomes as Open Radical Nephroureterectomy in T3N0M0 Upper Tract Urothelial Carcinoma? A Multicenter Cohort Study Adjusted by Propensity Score Matching

Shigeta K, Kikuchi E, Abe T, Hagiwara M, Ogihara K, Takeda T, Matsumoto K, Mizuno R, Jinzaki M, Oya M

AUA Annual Meeting, 

2019年05月

High gamma-globulin level is associated with oncological outcomes in patients with non-muscle invasive bladder cancer

Niwa N, Matsumoto K, Ide H, Oya M

AUA Annual Meeting, 

2019年05月

Site specific differences in survival among bladder, renal pelvic, and ureteral urothelial carcinoma patients treated with radical surgery

Anno T, Kikuchi E, Ogihara K, Oya M

AUA Annual Meeting, 

2019年05月